These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22159832)

  • 21. 3-year follow-up of 215 fracture patients from a prospective and consecutive osteoporosis screening program. Fracture patients care!
    Astrand J; Thorngren KG; Tägil M; Akesson K
    Acta Orthop; 2008 Jun; 79(3):404-9. PubMed ID: 18622846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The management of osteoporosis following hip fracture: have we improved our care?
    Bahl S; Coates PS; Greenspan SL
    Osteoporos Int; 2003 Nov; 14(11):884-8. PubMed ID: 14569422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of two geriatric treatment systems with anti-osteoporotic drug treatment and second hip fracture in patients with an index hip fracture: retrospective cohort study.
    Rapp K; Roigk P; Becker C; Todd C; Rehm M; Rothenbacher D; Konnopka C; König HH; Friess T; Büchele G
    BMC Geriatr; 2024 May; 24(1):395. PubMed ID: 38702593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.
    Reginster JY; Felsenberg D; Boonen S; Diez-Perez A; Rizzoli R; Brandi ML; Spector TD; Brixen K; Goemaere S; Cormier C; Balogh A; Delmas PD; Meunier PJ
    Arthritis Rheum; 2008 Jun; 58(6):1687-95. PubMed ID: 18512789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study.
    Hadji P; Papaioannou N; Gielen E; Feudjo Tepie M; Zhang E; Frieling I; Geusens P; Makras P; Resch H; Möller G; Kalouche-Khalil L; Fahrleitner-Pammer A
    Osteoporos Int; 2015 Oct; 26(10):2479-89. PubMed ID: 26018090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis.
    Desai RJ; Mahesri M; Abdia Y; Barberio J; Tong A; Zhang D; Mavros P; Kim SC; Franklin JM
    JAMA Netw Open; 2018 Jul; 1(3):e180826. PubMed ID: 30646034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal change in clinical fracture incidence after initiation of bisphosphonates.
    Abelson A; Ringe JD; Gold DT; Lange JL; Thomas T
    Osteoporos Int; 2010 Jun; 21(6):1021-9. PubMed ID: 19722103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study.
    Prentice RL; Pettinger MB; Jackson RD; Wactawski-Wende J; Lacroix AZ; Anderson GL; Chlebowski RT; Manson JE; Van Horn L; Vitolins MZ; Datta M; LeBlanc ES; Cauley JA; Rossouw JE
    Osteoporos Int; 2013 Feb; 24(2):567-80. PubMed ID: 23208074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterisation of patients with postmenopausal osteoporosis in French primary healthcare.
    Blotman F; Cortet B; Hilliquin P; Avouac B; Allaert FA; Pouchain D; Gaudin AF; Cotté FE; El Hasnaoui A
    Drugs Aging; 2007; 24(7):603-14. PubMed ID: 17658910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Risk factors for osteoporosis in women having hip fractures after 60 years of age].
    Unay K; Demirçay E; Akan K; Sener N
    Acta Orthop Traumatol Turc; 2005; 39(4):295-9. PubMed ID: 16269875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orthopedic-Metabolic Collaborative Management for Osteoporotic Hip Fracture.
    Rotman-Pikielny P; Frankel M; Lebanon OT; Yaacobi E; Tamar M; Netzer D; Nabriski D; Nyska M; Brin YS
    Endocr Pract; 2018 Aug; 24(8):718-725. PubMed ID: 30084682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zoledronic acid increases bone mineral density and improves health-related quality of life over two years of treatment in Chinese women with postmenopausal osteoporosis.
    Huang S; Lin H; Zhu X; Chen X; Fan L; Liu C
    Endokrynol Pol; 2014; 65(2):96-104. PubMed ID: 24802732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium, vitamin D, milk consumption, and hip fractures: a prospective study among postmenopausal women.
    Feskanich D; Willett WC; Colditz GA
    Am J Clin Nutr; 2003 Feb; 77(2):504-11. PubMed ID: 12540414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Missed opportunities for osteoporosis treatment in patients hospitalized for hip fracture.
    Jennings LA; Auerbach AD; Maselli J; Pekow PS; Lindenauer PK; Lee SJ
    J Am Geriatr Soc; 2010 Apr; 58(4):650-7. PubMed ID: 20398147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are antiresorptive drugs effective against fractures in patients with diabetes?
    Vestergaard P; Rejnmark L; Mosekilde L
    Calcif Tissue Int; 2011 Mar; 88(3):209-14. PubMed ID: 21161194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Denosumab utilization among older adults in Ontario: patient characteristics, persistence with therapy, and return to therapy after an extended gap.
    Ban JK; Hao BB; McCarthy L; Guilcher SJT; Cadarette SM
    Osteoporos Int; 2019 Sep; 30(9):1865-1872. PubMed ID: 31317248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo Osteoporosis Epidemiology Study.
    Chang KP; Center JR; Nguyen TV; Eisman JA
    J Bone Miner Res; 2004 Apr; 19(4):532-6. PubMed ID: 15005838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and Safety of Zoledronic Acid for Treatment of Postmenopausal Osteoporosis: A Meta-Analysis of Randomized Controlled Trials.
    Wang C
    Am J Ther; 2017; 24(5):e544-e552. PubMed ID: 26938765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteoporosis: latest innovation in therapy.
    Taechakraichana N; Witoonpanich P
    J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S126-31. PubMed ID: 21213509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.